HIV Infections Clinical Trial
Official title:
A Randomized Controlled Trial Embedded in an Electronic Medical Record (myHERO).
This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that contains personal health information like medications, diagnosed conditions, allergies and laboratory values (like CD4 cells and viral load). This study will also help explain if a personal health record influences the relationship with a doctor or nurse practitioner and their patients. The purpose of this study is to determine if a personal health record will influence health. The content of your personal health record is as secure as possible for any online health information.
HIV/AIDS is a non-curable chronic illness. Applying the chronic care model (CCM) to this
disease may lead to improved outpatient based health care and easier clinical transitions
for HIV infected patients. Clinical information systems (CIS) are a key element in the CCM
and have three important roles: reminder systems; feedback mechanisms; and registries. CIS
have focused on the provider as the recipient of critical data, however clinical information
systems that target patients as consumers of information might also contribute to improved
health care, especially for ambulatory patients. Personal health records (PHRs) are tools
that would fit as a clinical information system for patients. PHRs allow patients (and
others) to view data that are necessary to guide practical outpatient decisions. PHRs can
become platforms to support the CIS elements too, allowing patients to receive and
understand information, engage in their healthcare and influence their health outcomes. Our
central hypothesis is that a secure enhanced PHR (ePHR) that combines meaningful
information, web-based tools for support and reminders for patients will also provide a
substantial opportunity to promote self-management and will lead to improved health
outcomes. In this proposal we will work directly with HIV/AIDS patients in a public health
setting to model processes that contribute to improved health outcomes in the realms of
patient behaviors, patient-clinician trust, clinical outcomes, medication safety and
utilization. Accordingly, the specific aims are:
1. (Build Infrastructure and Content) Extend and secure a web-based PHR for HIV/AIDS
patients receiving care in a public health setting providing these users with tools to
access and understand their medical record including resources for decision support,
information retrieval and communication. Specific content will include access to
support for tobacco cessation, depression abatement, anxiety reduction, and medication
adherence improvement.
2. (Evaluation of PHR) Evaluation of patient and clinician experience with PHR including
patient access and use patterns including use of support for tobacco cessation,
depression abatement, anxiety reduction, adherence improvement., patient and clinician
satisfaction with ePHR.
3. (Outcome Assessment) Evaluation in 5 domains: quality of the patient-clinician
interaction (trust, communication, health promotion); changes in patient behaviors
(risk behaviors, adherence to antiretroviral medications, tobacco use); clinical
outcomes (CD4+ T-lymphocytes, detectable plasma HIV RNA, depression, anxiety, quality
of life); safety (documentation of drug allergies, adverse events, medication
reconciliation); and utilization (office visits).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05454514 -
Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS
|
N/A | |
Completed |
NCT03760458 -
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
|
Phase 1/Phase 2 | |
Completed |
NCT03067285 -
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
|
Phase 4 | |
Completed |
NCT03141918 -
Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS
|
N/A | |
Recruiting |
NCT04579146 -
Coronary Artery Disease (CAD) in Patients HIV-infected
|
||
Completed |
NCT06212531 -
Papuan Indigenous Model of Male Circumcision
|
N/A | |
Active, not recruiting |
NCT03256422 -
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients
|
Phase 3 | |
Completed |
NCT03256435 -
Retention in PrEP Care for African American MSM in Mississippi
|
N/A | |
Completed |
NCT00517803 -
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
N/A | |
Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
Completed |
NCT04165200 -
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
N/A | |
Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT02234882 -
Study on Pharmacokinetics
|
Phase 1 | |
Completed |
NCT01618305 -
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
|
Phase 4 | |
Recruiting |
NCT05043129 -
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
|
||
Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
Recruiting |
NCT04985760 -
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
|
Phase 1 | |
Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
Terminated |
NCT02116660 -
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
|
Phase 2 |